Transcription of Public Assessment Report Decentralised Procedure - …
{{id}} {{{paragraph}}}
Example: dental hygienist
Public Assessment Report Decentralised Procedure - …
PAR Sildenafil 25 mg, 50 mg and 100 mg film -coated tablets PL 34771/0143-5; UK/H/4673/001-3/DC 1 Public Assessment Report Decentralised Procedure Sildenafil 25 mg film -coated tablets Sildenafil 50 mg film -coated Tablets Sildenafil 100 mg film -coated tablets UK/H/4673/001-3/DC UK licence numbers: PL 34771/0143-5 Macleods Pharma UK Limited PAR Sildenafil 25 mg, 50 mg and 100 mg film -coated tablets PL 34771/0143-5; UK/H/4673/001-3/DC 2 LAY SUMMARY On 02 July 2012, the MHRA granted Macleods Pharma UK Limited Marketing Authorisations (licences) for the medicinal products, Sildenafil 25 mg, 50 mg and 100 mg film -coated tablets (PL 34771/0143-5). These are prescription-only medicines (POM). Sildenafil belongs to a group of medicines called phosphodiesterase type 5 (PDE5) inhibitors. It works by helping to relax the blood vessels in your penis, allowing blood to flow into your penis when you get sexually excited.
PAR Sildenafil 25 mg, 50 mg and 100 mg film-coated tablets PL 34771/0143-5; UK/H/4673/001-3/DC 1 Public Assessment Report Decentralised Procedure
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: